Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:IMPAC_Medical_Systems
gptkb:Nucletron Philips Radiation Oncology Systems |
| gptkbp:CEO |
gptkb:Gustaf_Salford
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:focusesOn |
gptkb:cancer
neurosurgery |
| gptkbp:foundedBy |
gptkb:Lars_Leksell
|
| gptkbp:foundedYear |
1972
|
| gptkbp:headquartersLocation |
gptkb:Stockholm
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elekta AB
|
| gptkbp:industry |
medical device
|
| gptkbp:ISIN |
SE0000163628
|
| gptkbp:logo |
Elekta logo.svg
|
| gptkbp:numberOfEmployees |
approximately 4,700
|
| gptkbp:products |
gptkb:Gamma_Knife
linear accelerators oncology information systems brachytherapy systems |
| gptkbp:publiclyTraded |
gptkb:Nasdaq_Stockholm
|
| gptkbp:revenue |
SEK 14.5 billion (2023)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:Stockholm_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:EKTA-B
|
| gptkbp:subsidiary |
gptkb:Elekta_Instrument_AB
|
| gptkbp:website |
https://www.elekta.com/
|
| gptkbp:bfsParent |
gptkb:IMPAC_Medical_Systems,_Inc.
|
| gptkbp:bfsLayer |
7
|